Bladder Cancer Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Data On PEDIGREE Trial For Kidney Cancer
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate, and testicular cancers, Discusses Data On PE... Author: kidneycancer Added: 01/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2019 Category: Cancer & Oncology Source Type: podcasts

CheckMate 214 Data Presentation
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate, and testicular cancers, Discusses CheckMate ... Author: kidneycancer Added: 01/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Next Step In Tumor Resection
Alexander Kutikov, M.D. Chief, Division of Urology and Urologic Oncology Professor At Fox Chase Cancer Center, Department of Surgical Oncology Kidney, Bladder, and Prostate Cancer TRDG Member, discuss... Author: kidneycancer Added: 01/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2019 Category: Cancer & Oncology Source Type: podcasts

Discussing Debate On Tumor Enucleation
Alexander Kutikov, M.D. Chief, Division of Urology and Urologic Oncology Professor At Fox Chase Cancer Center, Department of Surgical Oncology Kidney, Bladder, and Prostate Cancer TRDG Member, discuss... Author: kidneycancer Added: 01/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2019 Category: Cancer & Oncology Source Type: podcasts

Systemic treatments for non-muscle invasive bladder cancer
Speaking from the 2018 Genitourinary Cancers Symposium in San Francisco, CA, Peter Black, MD, of the University of British Columbia, Vancouver, CA, outlines the development of systemic therapy for non... Author: VJOncology Added: 09/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 7, 2018 Category: Cancer & Oncology Source Type: podcasts

A bladder-sparing approach for muscle-invasive bladder cancer
From the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, Elizabeth Plimack, MD, from Fox Chase Cancer Center, Philadelphia, PA, introduces the key trials in progress at her center, in... Author: VJOncology Added: 09/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Can atezolizumab succeed where BCG fails in bladder cancer?
BCG immunotherapy is one of the primary treatment options for bladder cancer patients who are ineligible for cystectomy. However, some patients continue to have persistant high-grade disease long afte... Author: VJOncology Added: 09/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Future therapy options for muscle-invasive bladder cancer
Treatment for muscle-invasive bladder cancer has evolved as medical knowledge has expanded. Jeanny Aragon-Ching, MD, FACP, from Inova Schar Cancer Institue, Falls Church, VA, explains how, previously,... Author: VJOncology Added: 09/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Using biomarkers to identify bladder cancer patients for neoadjuvant therapy
In this video, Peter Black, MD, of the University of British Columbia, Vancouver, Canada, speaks to us about the use of biomarkers to identify bladder cancer patients eligible for neoadjuvant therapy.... Author: VJOncology Added: 09/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Differences in survival rates among non-urothelial bladder cancers
Jeanny Aragon-Ching, MD, FACP, of Inova Schar Cancer Institute, Falls Church, VA, discusses the differences in survival rates of non-urothelial bladder cancer patients at the Genitourinary Cancers Sym... Author: VJOncology Added: 09/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy for prostate, bladder and kidney cancer
In this video, Elizabeth Plimack, MD, from Fox Chase Cancer Center, Philadelphia, PA, discusses the progress made in prostate, bladder and kidney cancer. There have been significant advances in immuno... Author: VJOncology Added: 09/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Enfortumab vedotin: targeting bladder cancer
The American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, presented exciting updates in urothelial carcinoma. Here, Arlene Siefker-Radtke, MD, of the MD Anderson Cancer Center,... Author: VJOncology Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

Urothelial carcinoma treatment: the future
Arlene Siefker-Radtke, MD, of the MD Anderson Cancer Center, Houston, TX, reviews treatment options for bladder cancer. She highlights how MVAC is still used today, with clinical trials failing to ide... Author: VJOncology Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

Urothelial carcinoma treatment: the future
Arlene Siefker-Radtke, MD, of the MD Anderson Cancer Center, Houston, TX, reviews treatment options for bladder cancer. She highlights how MVAC is still used today, with clinical trials failing to ide... Author: VJHemOnc Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

Can We Effectively Target FGFR with the Novel Agent Erdafitinib for Muscle-Invasive Bladder Cancer? Highlights from ASCO 2018 (BMIC-050)
Dr. Daniel Goldstein reviews highlights in bladder cancer from ASCO 2018, including the novel agent erdafitinib as a treatment targeting fibroblast growth factor receptor (FGFR) alterations in muscle-... Author: BeaconMedIC Added: 08/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 8, 2018 Category: Cancer & Oncology Source Type: podcasts